Physician profile
Theodore Knatt
NPI 1871528448
$1,481.26
in general payments reported to CMS, 2019-2025
8 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.27 · 2022: $464 · 2023: $219 · 2024: $34.01 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $505 · Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $504.84 |
| Food and Beverage | $419.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $823.99 | 2023-2025 | Mako, Alphavent |
| Zimmer Biomet Holdings, INC. | $451.94 | 2022 | |
| Dynasplint Systems INC. | $92.27 | 2021 | |
| Merz Pharmaceuticals, LLC | $35.72 | 2023 | Xeomin |
| Ipsen Biopharmaceuticals, INC | $22.94 | 2023 | Dysport |
| Spinal Simplicity, LLC | $22.05 | 2023 | Ha Minuteman G3-R |
| Pacira Pharmaceuticals Incorporated | $19.95 | 2024 | Iovera, Zilretta, Exparel |
| Vericel Corporation | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Knatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.